EX-FILING FEES 4 ny20012143x4_ex107.htm FILING FEES TABLE

Exhibit 107

Calculation of Filing Fee Tables

FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
AMERICAN ONCOLOGY NETWORK, INC.
(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities
                             
               
Security
Type
 
Security
Class Title
 
Fee
Calculation
Rule
 
Amount
Registered(1)
 
Proposed
Maximum
Offering
Price Per
Unit
 
Maximum
Aggregate Offering
Price
 
Fee Rate
 
Amount of
Registration
Fee
               
Equity
 
Class A Common stock, $0.0001 par value per share
 
Rule 457(c) and 457(h) of the Securities Act of 1933 (2)
 
5,300,000(3)
 
$6.44
 
$34,132,000
 
$0.00014760
 
$5,037.89
         
Total Offering Amounts
     
$34,132,000
     
$5,037.89
         
Total Fee Offsets(4)
             
         
Net Fee Due
             
$5,037.89

(1)
Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of Common Stock, $0.0001 par value per share (“Common Stock”), of American Oncology Network, Inc.  (the “Registrant”) that become issuable under the American Oncology Network, Inc. 2023 Incentive Equity Plan (the “2023 Plan”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of the outstanding shares of Common Stock.

(2)
Estimated in accordance with Rules 457(c) and 457(h) under the Securities Act solely for the purpose of calculating the registration fee on the basis of $6.44 per share, which is the average of the high and low prices of the Registrant’s Common Stock on , 2023, as reported on the Nasdaq Capital Market.

(3)
Represents 5,300,000  shares of Class A Common Stock reserved for issuance pursuant to the 2023 Plan.

(4)
The Registrant does not have any fee offsets.